CBP Warns Pharma on Price Reporting

Posted 5/23/25

U.S. Customs and Border Protection reminds the trade community that under the Trump Administration's Executive Order, “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients,” the U.S. Department of Health and Human Services has published price targets for prescription drugs to lower health care costs for Americans. 

This item is available in full to subscribers.

Please log in to continue

Log in